Function Health’s $298M Bet on Preventive Care: Unit Economics, Competitive Dynamics, and the Quest for Scale
Quick Links: Knowledge Base, Podcast, and Social
Knowledge Base — search and filter every article and podcast episode by topic, section, and keyword: kb.onhealthcare.tech
Listen to the Podcast — every article is also available as an audio episode. Free subscribers get the public episodes; paid subscribers get the full archive including subscriber-only episodes. Listen on Apple Podcasts, Spotify, or browse all episodes on the Substack Podcast page.
For paid subscribers — your subscription unlocks the entire research archive (538+ deep-dives), every paid podcast episode, and full search inside the Knowledge Base. To listen to paid episodes in Apple or Spotify, link your Substack subscription via the show settings on those platforms (instructions inside the Substack app under Subscriptions → Podcast).
For free subscribers — free posts and free podcast episodes are always public on Apple/Spotify and Substack. Upgrade any time at onhealthcare.tech/subscribe to access the paid archive and paid episodes.
Follow on Social — X · YouTube · TikTok · Instagram
ABSTRACT
Function Health recently closed a $298 million Series B at a $2.5 billion valuation, one of the largest rounds in direct-to-consumer healthcare history. The company offers comprehensive annual lab testing packages for $499 per year, promising to track over 100 biomarkers with quarterly testing and physician consultations. This essay examines:
• Function’s business model and unit economics, including customer acquisition costs, lifetime value projections, and margin structure
• The implications of a $2.5B valuation for required growth trajectories and exit expectations
• Competitive landscape spanning direct-to-consumer lab testing, concierge medicine, and traditional preventive care
• Market sizing and addressable opportunity in the wellness-focused consumer segment
• Key risk factors including regulatory challenges, medical necessity standards, and insurance integration questions
• Growth trajectories and scenarios that could determine whether Function becomes a decade-defining healthcare company or a cautionary tale about late-stage venture excess
The analysis suggests Function’s success hinges on three critical factors: scaling to multi-million member count while maintaining reasonable CAC, achieving 70%+ annual retention to justify customer lifetime value assumptions that support the valuation, and potentially pivoting to B2B or insurance channels without undermining their DTC positioning.
TABLE OF CONTENTS
Introduction and the $2.5B Question
The Function Health Model Explained
Breaking Down the Unit Economics
What a $2.5B Valuation Actually Means
Competitive Landscape and Market Positioning
Total Addressable Market and Growth Constraints
The Path to Venture Scale Returns
Risk Factors and Ways This Goes Sideways
Conclusion and Investment Framework
Introduction and the $2.5B Question
Function Health just raised $298 million at a $2.5 billion post-money valuation and the healthcare venture community is either nodding in approval or screaming into the void depending on which chat groups you frequent. This is the kind of round that makes you stop and really interrogate your assumptions about what constitutes a reasonable valuation in consumer healthcare. For context, $2.5B is more than what many profitable healthcare companies with actual revenue scale trade at in the public markets. It’s the kind of number that implies Function isn’t just building a nice business, they’re building something that could fundamentally reshape how Americans think about preventive care.
